Literature DB >> 18978112

Lymphadenectomy and ovarian preservation in low-grade endometrial stromal sarcoma.

Jay P Shah1, Christopher S Bryant, Sanjeev Kumar, Rouba Ali-Fehmi, John M Malone, Robert T Morris.   

Abstract

OBJECTIVE: To report the impact on overall survival of lymphadenectomy and ovarian preservation in patients with endometrial stromal sarcoma.
METHODS: Data were extracted from the Surveillance, Epidemiology, and End Results Program from 1988 to 2005. Kaplan-Meier and Cox proportional hazards analyses were used to identify possible predictors for survival.
RESULTS: Nine hundred seventy women were reported with endometrial stromal sarcoma. The 384 women with low-grade endometrial stromal sarcoma had a younger age, earlier stage, and longer survival than the 320 women with high-grade lesions. Among the low-grade endometrial stromal sarcoma patients, the incidence of extrauterine disease was 25%, and lymph node metastasis was 7%. Univariable and multivariable analysis demonstrated lymph node metastasis and ovarian preservation were not significant prognostic factors for survival.
CONCLUSION: In low-grade endometrial stromal sarcoma, the risk of extrauterine spread and lymph node metastasis merit consideration for surgical staging. Neither lymph node metastasis nor ovarian preservation seems to affect the excellent overall survival of these patients. LEVEL OF EVIDENCE: II.

Entities:  

Mesh:

Year:  2008        PMID: 18978112     DOI: 10.1097/AOG.0b013e31818aa89a

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  33 in total

1.  Long-term medroxyprogesterone acetate therapy for low-grade endometrial stromal sarcoma.

Authors:  Mika Mizuno; Yasushi Yatabe; Akihiro Nawa; Toru Nakanishi
Journal:  Int J Clin Oncol       Date:  2011-08-10       Impact factor: 3.402

2.  Reproductive outcome after uterine-sparing surgery for endometrial stromal sarcoma.

Authors:  M L Sánchez-Ferrer; F Machado-Linde; B Ferri-Ñíguez; M Sánchez-Ferrer; J J Parrilla-Paricio
Journal:  Gynecol Oncol Case Rep       Date:  2012-10-09

3.  Prolonged long-term survival of low-grade endometrial stromal sarcoma patients with lung metastasis following treatment with medroxyprogesterone acetate.

Authors:  Kentaro Nakayama; Masako Ishikawa; Yutaka Nagai; Nobuo Yaegashi; Yoichi Aoki; Khoji Miyazaki
Journal:  Int J Clin Oncol       Date:  2010-03-10       Impact factor: 3.402

Review 4.  Current and future options in the management and treatment of uterine sarcoma.

Authors:  Khalid El-Khalfaoui; Andreas du Bois; Florian Heitz; Christian Kurzeder; Jalid Sehouli; Philipp Harter
Journal:  Ther Adv Med Oncol       Date:  2014-01       Impact factor: 8.168

5.  Uterine Sarcomas: Experience from a Tertiary Cancer Care Center from India.

Authors:  Syed Nusrath; Sandeep Bafna; R Rajagopalan; Subramanyeshwar Rao Thammineedi; K V V N Raju; Sujit Chyau Patnaik; Satish Pawar; Yugandhar Reddy; Ramachandra Nagaraju Chavali; Sudha S Murthy
Journal:  Indian J Surg Oncol       Date:  2019-01-05

Review 6.  Current management of uterine sarcomas.

Authors:  Elena García-Martínez; Lucas Egea Prefasi; Jesús García-Donas; Pedro Pablo Escolar-Pérez; Francisco Pastor; Antonio González-Martín
Journal:  Clin Transl Oncol       Date:  2011-05       Impact factor: 3.405

7.  [Uterine sarcoma treatment].

Authors:  G Köhler
Journal:  Pathologe       Date:  2009-07       Impact factor: 1.011

8.  Endometrial stromal sarcoma arising in vagina.

Authors:  Zhaoxia Liu; Jiao Ding; Xia Li; Kehan Yu
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

9.  Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015).

Authors:  D Denschlag; F C Thiel; S Ackermann; P Harter; I Juhasz-Boess; P Mallmann; H-G Strauss; U Ulrich; L-C Horn; D Schmidt; D Vordermark; T Vogl; P Reichardt; P Gaß; M Gebhardt; M W Beckmann
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-10       Impact factor: 2.915

10.  Investigation of hormone receptor expression and its prognostic value in endometrial stromal sarcoma.

Authors:  Jeong-Yeol Park; Min-Hyun Baek; Yangsoon Park; Young-Tak Kim; Joo-Hyun Nam
Journal:  Virchows Arch       Date:  2018-06-04       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.